Showing results (1451-1460 of 1,540) with videos related to
Sort By:
Pageof 154
Bioorganic & Medicinal Chemistry|February 9, 2005
In vitro and in vivo profile of 2-(3-di-fluoromethyl-5-phenylpyrazol-1-yl)-5-methanesulfonylpyridine, a potent, selective, and orally active canine COX-2 inhibitorJin Li, Michael P Lynch, Kristin Lundy Demello, et al.Cancer Discovery|March 26, 2026
Machine learning predicts hepatocellular carcinoma risk from routine clinical data: a large population-based multicentric studyJan Clusmann, Paul-Henry Koop, David Y Zhang, et al.Community Dentistry and Oral Epidemiology|November 21, 2018
Chewing function, general health and the dentition of older Australian men: The Concord Health and Ageing in Men ProjectFredrick A C Wright, Garry G Law, Kate L Milledge, et al.Plos One|July 9, 2024
Correction: Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung CancerHuifang Hao, Yutaka Maeda, Takuya Fukazawa, et al.Allergy|February 20, 2022
Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer studyDiego Alvarado, Marcus Maurer, Richard Gedrich, et al.Journal of Virology|September 8, 2022
Avatar Mice Underscore the Role of the T Cell-Dendritic Cell Crosstalk in Ebola Virus Disease and Reveal Mechanisms of Protection in SurvivorsMonika Rottstegge, Tom Tipton, Lisa Oestereich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study GroupNita L Seibel, Sierra Li, Norman E Breslow, et al.Neurourology and Urodynamics|April 14, 2025
Association Between Urodynamic Findings and Urinary Retention After Onabotulinumtoxin A for Idiopathic Overactive BladderAnjali Kapur, Monica Van Til, Stephanie Daignault-Newton, et al.Nature Communications|May 19, 2018
A novel small molecule chaperone of rod opsin and its potential therapy for retinal degenerationYuanyuan Chen, Yu Chen, Beata Jastrzebska, et al.Blood|November 15, 2007
Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology groupBeverly J Lange, Franklin O Smith, James Feusner, et al.Pageof 154